Hypertension. 2000;35:685-690
(Hypertension. 2000;35:685.)
© 2000 American Heart Association, Inc.
Vascular Response to Angiotensin II in Atherosclerosis
Role of the Baroreflex
Klaus Wilfert;
Klaus Drischel;
Axel Unbehaun;
Hans Guski;
Pontus B. Persson;
Harald M. Stauss
From the Johannes-Müller-Institut für Physiologie (K.W., K.D.,
A.U., P.B.P., H.M.S.) and Institut für Pathologie (H.G.),
Humboldt-Universität (Charité), Berlin, Germany.
Correspondence to Klaus Wilfert, MD, Department of Physiology, Humboldt University Berlin, Charité, Tucholskystrasse 2, 10117 Berlin, Germany. E-mail klaus.wilfert{at}charite.de
 |
Abstract
|
|---|
AbstractHigh-cholesterol
alimentation is associated
with an induction of
angiotensin-converting enzyme and angiotensin
II receptor expression within the vascular wall of the aorta.
Despite
an enhanced pressure response to angiotensin II in
atherosclerotic conscious rabbits, angiotensin IIinduced
contraction was reduced in isolated vascular rings from the
aorta and
unchanged in those from the iliac artery. We, therefore,
investigated
whether cholesterol-induced atherosclerosis
enhances
overall vascular responsiveness to angiotensin II
in intact
animals and whether an altered arterial
baroreflex sensitivity
can explain the discrepancy between experiments
in intact animals
and isolated blood vessels. Rabbits were maintained
on a high-cholesterol
diet (2 g/d cholesterol
plus 20 mL/d sunflower seed oil, n=11)
or on a standard diet (n=12) for
12 weeks. Total serum lipids
markedly increased
(
P<0.05). Tissue examinations 6 weeks
after termination
of the high-cholesterol diet revealed distinct
atherosclerosis and elevated cholesterol
content in the aorta
(
P<0.05). A
high-cholesterol diet did not change baseline
hemodynamic parameters. However,
angiotensin IIinduced
increases in total
peripheral resistance were larger in the
atherosclerotic
animals (86.3±13.0 versus 41.9±9.7
mm Hg ·
L
-1 · min,
P<0.05). In addition,
the
blood pressure pulse interval relationship was markedly reduced
(slope: 0.80±0.14 versus 0.49±0.06 ms/mm Hg,
P<0.05), which suggested that the baroreflex blunted
the
angiotensin II response to a lesser extent in
atherosclerotic
animals. In conclusion, the overall vascular
responsiveness
to angiotensin II is increased in the
atherosclerotic rabbit
as indicated by the larger increase in total
peripheral resistance.
An attenuation of the
arterial baroreflex sensitivity may contribute
to this
effect.
Key Words: rabbits cholesterol vasoconstriction cardiac output total peripheral resistance
 |
Introduction
|
|---|
Excessive cholesterol alimentation causes
hypercholesterolemia
and eventually
atherosclerosis.
1 2 3 Hypertension is
another
important risk factor for
atherosclerosis.
4 On the other hand,
several studies have reported that blood pressure regulation,
especially the control of vascular tone, is affected by
high-cholesterol
serum levels.
3 5 For
instance, vascular responsiveness to
norepinephrine has
been reported to be enhanced in animals
maintained on a
high-cholesterol diet.
6 7 8 However,
inconsistent
results have been reported on vascular
responsiveness to angiotensin
II (Ang II). The constrictor
response of aortic rings to Ang
II was found to be markedly enhanced in
one study
3 and reduced
in another study.
9
With regard to other vascular beds, iliac
artery rings from
cholesterol-fed rabbits also did not exhibit
an enhanced
response to Ang II,
9 and intrarenal Ang II infusion
had a
similar effect on renal vascular constriction in control
rabbits and
rabbits with a high-nutritional cholesterol
intake.
10 Because of these discrepant responses to Ang II
in different
isolated vascular beds, one can speculate that the altered
cardiovascular
control in the atherosclerotic rabbit
model may not solely
be confined to the vessel and end organ response.
Despite the
nonuniform responses to Ang II found in isolated
vessels,
3 9 the effect of Ang II on arterial
blood pressure was enhanced
in atherosclerotic conscious
rabbits.
11 Total peripheral resistance
was not
determined in the latter study; thus, it remains unclear
whether this
larger pressure increase relies on an enhanced
vascular responsiveness.
Alternatively, blood pressure controlling
mechanisms, eg, the
arterial baroreceptor reflex, could be
altered in animals
maintained on a high-cholesterol diet and,
therefore, may
be responsible for the larger pressure response
to Ang II in intact
animals. In particular, the vascular response
to Ang II may be blunted
to a lesser extent by the baroreceptor
reflex in atherosclerotic
animals. This would explain a stronger
increase in total
peripheral resistance in vivo, whereas the
vascular
response to Ang II would be unaltered in the absence
of the baroreflex,
ie, in isolated blood vessels. The present
study was performed to
examine the effect of systemically administered
Ang II on
arterial blood pressure and total peripheral
resistance
in the hypercholesterolemic rabbit. In
addition, we determined
arterial baroreceptor reflex
sensitivity in rabbits maintained
on a high-cholesterol
diet to investigate whether this important
blood pressure regulating
mechanism is impaired by hypercholesterolemia
and, therefore, can explain the different responses to Ang
II in
isolated blood vessels and intact animals.
 |
Methods
|
|---|
Experimental Animals and Atherogenic Diet
Nine-month-old locally bred rabbits of both genders (3.6±0.1
kg
bw) were housed individually under constant climate conditions
and had
free access to drinking water. After an acclimatization
period of 4
weeks, rabbits were randomly assigned to 1 of 2
groups: The control
group received a standard diet of 130 g/d
(n=12). The experimental
group (n=11) was given the same basic
diet, to which 2 g
cholesterol and 20 mL sunflower seed oil
were added. These
diets were given for 12 weeks, before the
high-cholesterol
diet was discontinued and both groups received
the same standard diet
for an additional 6 weeks. Then, hemodynamic
measurements were performed. Venous blood samples were drawn
at the
onset of the study, on 4 occasions during the
high-cholesterol
feeding period, and at the end of the
study. Three days of
noncholesterol feeding were allowed
before blood sampling to
avoid excessive lipid plasma levels and
consecutive hemolysis.
Serum values for total lipids, glucose, and the
following enzymes
were assessed: glutamic-oxalacetic-transaminase
(GOT), glutamic-pyruvic-transaminase
(GPT), lactate-dehydrogenase
(LDH), and

-hydroxybutyrate-dehydrogenase
(

-HBDH).
Animal Preparation and Experimental Protocol
Rabbits were anesthetized with urethane (1.5 g/kg bw,
IV) and placed on a thermostat table (Zimmerman, Leipzig,
Germany). Catheters for pressure measurements were positioned in
the left ventricle, in the abdominal aorta, and in the vena cava.
Additional catheters were implanted in both femoral veins for infusion
of Ang II and injection of the indicator solution for determination of
cardiac output. Pressure amplifiers provided the
ventricular, arterial, and central venous
pressure and the differentiated left ventricular pressure
signal (LV dP/dt). Heart rate was obtained from the ECG, and
end-diastolic pressure was obtained from the left
ventricular pressure signal using the ECG as a trigger
signal.12 The maximum of the LV dP/dt signal (LV
dP/dtmax) and its ratio to the instantaneous
pressure (LV dP/dtmax/P) were used as markers for
myocardial contractility. Cardiac output was measured
by the indocyanine dye dilution method, a modification of the technique
described by Angell-James et al.13 A stabilization period
of 30 to 45 minutes was allowed before hemodynamic
measurements were performed in anesthetized and spontaneously
breathing rabbits. An initial baseline period of 5 minutes was followed
by an intravenous infusion of 0.4 µg ·
kg-1 · min-1 Ang
II. This dose was selected on the basis of both the
literature11 14 and pilot experiments in which we applied
doses in the range of 0.4 to 4.0 µg ·
kg-1 · min-1. The
dose of 0.4 µg · kg-1 ·
min-1 is within the range of the upper plateau
of the dose-response curve for blood pressure.14 Ang II
infusion was stopped after 15 minutes, and the recording was
continued for a final recovery period of 5 minutes. Cardiac output,
stroke volume, and total peripheral resistance were
determined in the initial baseline period and during the 3rd and 14th
minute of Ang II infusion. Baroreceptorheart rate reflex sensitivity
was assessed by linear regressions between arterial
pressure and heart period with the pressure increase and
decrease that occurred in response to the onset of Ang II infusion (0.4
µg · kg-1 ·
min-1) and its termination, respectively. These
sections of the recordings lasted for
3 minutes. Only linear
regressions with regression coefficients >0.85 were considered.
Eight hours after the hemodynamic measurements, both
ventricles, the abdominal and thoracic sections of the aorta, the
carotids, and the quadriceps muscle were taken for lipid chemical and
histological examinations. The
myocardium was inspected for necrotic lesions, scar tissue,
and fibrosis. In addition, conduit vessels (aorta, carotids, and
coronary arteries) and arterioles in the perivascular tissue of
the aorta and carotids as well as within the myocardium
were examined morphometrically with special attention to
atherosclerosis.
Statistics
Data are mean±SEM. Comparisons between both dietary groups were
performed by unpaired t tests. Time courses were tested by
2-way ANOVA (time versus dietary treatment). Post hoc t
tests were performed to test individual differences, if the 2-way ANOVA
revealed statistical significance. Statistical significance was assumed
at P<0.05.
 |
Results
|
|---|
Serum Lipids and Tissue Cholesterol
A high-cholesterol diet increased total serum
lipid levels,
which dramatically decreased 6 weeks after the
high-cholesterol
intake period, ie, at week 18 (Figure 1A
). Control values, however,
were not
fully restored. Serum glucose levels did not differ
between dietary
groups. The serum activities of GOT, GPT, LDH,
and

-HBDH increased
temporarily during the high-cholesterol
feeding period and
returned to normal at the end of the 6-week
postcholesterol
period.

View larger version (23K):
[in this window]
[in a new window]
|
Figure 1. A, Time course of total serum lipids.
high-cholesterol diet, n=11. standard diet, n=12.
#P<0.05 high-cholesterol diet vs standard
diet. B, Cholesterol content in the aorta, the ventricles,
and skeletal muscle. Gray bars: high-cholesterol diet,
n=11. White bars: standard diet, n=12. #P<0.05
high-cholesterol diet vs standard diet.
|
|
Tissue cholesterol content in the aorta was increased
4-fold by high-cholesterol alimentation, whereas
cholesterol content in the myocardium and
skeletal muscle did not rise significantly (Figure 1B). The
pathohistological effects of a
high-cholesterol diet on the vascular system are shown in
Figure 2. At week 18, a marked
atherosclerosis was observed in the conduit vessels but
not in the resistance vessels. The extent of the myocardial lesions
(granulation tissue and scars) was only 1.3% on average. None of the
animals included in this study had myocardial tissue damage of >4%.
Fresh myocardial necroses were not observed.

View larger version (99K):
[in this window]
[in a new window]
|
Figure 2. A, Cross section of a carotid artery from a rabbit
fed a high-cholesterol diet for 12 weeks. Marked intima
thickening can be observed. B, Cross section of a carotid artery from
an age-matched rabbit fed a standard diet.
|
|
Hemodynamic Effects of Ang II
To minimize potential influences of excessively high serum lipid
and cholesterol levels on the hemodynamic
measurements, these recordings were performed at week 18, ie, 6
weeks after the high-cholesterol diet was terminated.
Baseline hemodynamic conditions at week 18 are provided
in Table 1. Significant differences were
not found between the 2 groups. No hemodynamic signs of
cardiac dysfunction were observed. Infusion of Ang II initially caused
an increase in arterial blood pressure of
20 mm Hg
in both groups. Despite the continuous infusion of Ang II, blood
pressure gradually declined in both groups and reached baseline levels
at the end of the infusion (minute 14) in the control group but not in
the high cholesterol group (Figure 3, top). Ang II infusion also decreased
heart rate in control rabbits (Figure 3, middle), which was
probably caused by activation of the arterial baroreceptor
reflex. In contrast, rabbits that had been maintained on a
high-cholesterol diet for 12 weeks did not show a reduced
heart rate to the same extent, indicating a reduced baroreceptorheart
rate reflex sensitivity. Left ventricular
end-diastolic pressure increased significantly during Ang
II infusion in both groups (Figure 3, bottom). The
contractility index LV dP/dtmax/P
similarly decreased in both groups (Figure 3, bottom). Ang
IIinduced changes in cardiac output, mean arterial
pressure, and total peripheral resistance at the 3rd and
14th minute of Ang II infusion are shown in Figure 4. A significantly diminished cardiac
output was found for the group that was fed cholesterol.
The increase in total peripheral resistance associated with
the Ang II infusion was more pronounced in rabbits that received the
atherogenic diet. At the end of Ang II infusion, this difference in the
overall vascular response to Ang II reached statistical
significance.

View larger version (33K):
[in this window]
[in a new window]
|
Figure 3. Time course of mean arterial blood
pressure (MAP), heart rate (HR), left ventricular
end-diastolic pressure (LVEDP), and myocardial
contractility index (LV dP/dtmax/P). :
high-cholesterol diet, n=11. : standard diet, n=12.
*P<0.05 absolute values during Ang II infusion vs
baseline values.
|
|

View larger version (25K):
[in this window]
[in a new window]
|
Figure 4. Ang IIinduced changes in cardiac output (CO),
MAP, and total peripheral resistance (TPR). Gray bars:
high-cholesterol diet, n=11. White bars: standard diet,
n=12. *P<0.05 absolute values at the 3rd and 14th
minute of Ang II infusion vs baseline values. #P<0.05
high-cholesterol diet vs standard diet.
|
|
Arterial Baroreflex Sensitivity
The slope relating pulse interval to arterial blood
pressure was less steep in the rabbits that received the
high-cholesterol diet (Figure 5). This can be taken as a sign for a
blunted baroreceptorheart rate reflex sensitivity. This
interpretation is further substantiated by the heart rate time course
depicted in Figure 3. Although mean arterial
pressure increased almost to a similar amount in both groups, or even
slightly more in the high-cholesterol group at the end of
the infusion, bradycardia was stronger in the control animals.

View larger version (29K):
[in this window]
[in a new window]
|
Figure 5. Relationship between changes in MAP and interbeat
interval (IBI) associated with initiation (positive MAP values) and
termination (negative MAP values) of Ang II infusion. Solid line:
high-cholesterol diet, n=11. Dashed line: standard diet,
n=12. Shaded areas: confidence intervals. Inset: slopes of the linear
relationships between the changes in MAP and IBI.
#P<0.05 high-cholesterol diet (HCD) vs
standard diet (SD).
|
|
 |
Discussion
|
|---|
This study demonstrates an enhanced increase in total
peripheral
resistance in response to systemically applied
Ang II in atherosclerotic
rabbits. In addition, a reduced baroreceptor
reflex sensitivity
was observed, giving rise to the hypothesis that the
enhanced
vascular responsiveness to Ang II in
atherosclerosis is not
solely related to an altered
vascular function, but also relies
on an impaired arterial
baroreceptor reflex.
High-cholesterol feeding markedly increased total serum
lipids and vascular cholesterol content (Figure 1)
and thus caused atherosclerosis (Figure 2).
Studies in isolated vessels from atherosclerotic rabbits are equivocal
with regard to the vasoconstrictor response to Ang II. Dam and
coworkers9 found a reduced response in aortic rings and no
difference in iliac arteries. In contrast, Yang et al3
found an enhanced response to Ang II in aortic rings. In vivo studies
are also difficult to reconcile. For example, Hof and
Hof11 describe an enhanced pressure effect of systemically
administered Ang II, while Carroll et al10 found that both
the systemic pressure response and the renal vasoconstrictor response
to intrarenal Ang II infusions were similar in control and
atherosclerotic rabbits. This diversity within the literature prompted
us to test whether the overall vascular responsiveness to Ang II is
enhanced in atherosclerosis and whether an impairment
of cardiovascular control mechanisms adds to this
hyperresponsiveness. According to this hypothesis, the vasoconstrictor
response to Ang II would be less effectively antagonized by the
baroreflex and, consequently, cause a stronger increase in total
peripheral resistance in atherosclerosis.
This interpretation was, indeed, substantiated by the present
study. First, total peripheral resistance increased more in
response to systemically administered Ang II in atherosclerotic rabbits
(Figure 4). Second, baroreflex sensitivity to the heart was
markedly reduced in cholesterol-fed animals (Figure 5). Accordingly, the bradycardic response to the Ang IIinduced
hypertension was blunted in cholesterol-fed animals, which
would be expected if the baroreflexes were impaired (Figure 3).
Third, resistance vessels were excluded from the atherosclerotic
process, suggesting a contribution of extravascular mechanisms to the
increased vascular response to Ang II.
Recent in vitro experiments on the effects of Ang II in atherosclerotic
vessels support our findings obtained in the whole animal: Yang and
colleagues demonstrated a 5-fold increase in Ang II receptor
expression,3 and Song et al have observed an increased
angiotensin-converting enzyme activity in atherosclerotic
vessels.2 The latter group also found that Ang II type 1
receptor density increased in the medial lesion. Thus, a basis exists
for assuming that the vasoconstrictor response of conduit vessels to
Ang II is enhanced. In spite of the pronounced
atherosclerosis and enhanced vascular response to Ang
II, baseline blood pressure was not higher in
cholesterol-fed rabbits (Table 1). Similar results
were found by Zuckerman et al15 after 11 weeks of
high-cholesterol feeding in rabbits. However, after a
longer dietary cholesterol challenge, hypertension may
occur. Angell-James16 found a significant increase in
baseline blood pressure after a high-cholesterol diet of
67 weeks. We recorded arterial blood pressure 6 weeks
after cholesterol feeding was terminated. Thereby, abnormal
serum enzyme activities or excessively high serum levels of
cholesterol and serum lipids were avoided. Thus, we cannot
rule out that arterial blood pressure may have been higher
during the 12 weeks of high-cholesterol feeding and
returned to normotensive values within the postcholesterol
period. Furthermore, the kidney, a key organ in the control of
arterial blood pressure, may have effectively prevented
hypertension in the present study. At least from a functional point
of view, renal vascular resistance is not affected by a
high-cholesterol diet nor is the renal vascular response to
Ang II changed.10 When observed morphologically, the renal
microvasculature seems to be protected, perhaps by an increase in
cholesterol esterase.17
A reduced afferent baroreceptor activity in atherosclerotic animals was
first described by Angell-James.16 With an elegant
approach, she performed nerve recordings from the aortic nerve
while locally altering aortic arch pressure. Compared with controls,
lower frequencies in the impulse discharges of afferent baroreceptor
fibers in atherosclerotic rabbits were found, indicating that the
afferent arch of the baroreflex is on fault in
atherosclerosis. Like other
investigators,18 19 20 21 we also found a reduced
baroreceptorheart rate reflex in atherosclerosis.
Because primarily the afferent portion of the reflex is impaired in
atherosclerosis,16 one can expect that the
sensitivity of both the baroreceptor-sympathetic nerve activity reflex
and the baroreceptorheart rate reflex is reduced in
atherosclerosis. Indeed, it has been demonstrated that
baroreflex control of sympathetic renal nerve activity is depressed in
conscious WHHL rabbits.18 Thus, the Ang IIinduced
increase in arterial blood pressure may elicit a smaller
reduction in sympathetic nerve activity directed to the resistance
vessels and, hence, may add to the enhanced vascular responsiveness to
Ang II in vivo. There are several levels at which
atherosclerosis can blunt the baroreflex. Li and
associates have shown that endogenous oxygen-derived
radicals, which can be produced by atherosclerotic vessels, attenuate
the carotid nerve response to pressure changes.22
Furthermore, platelet activation in carotid sinuses, a common site
of atherosclerotic lesions, which may facilitate platelet
aggregation, markedly attenuates reflex-mediated changes in renal
sympathetic nerve activity.23 Altered vessel wall
structure as a result of
hypercholesterolemia24 may also
account for an attenuated baroreflex, because increased aortic and
carotid vessel stiffness can change baroreflex
characteristics.25 Yet, it seems unlikely that an
attenuation of the arterial baroreflex is due to heart
failure.26 27 Although interspersed scar tissue was
detected in the ventricles, none of the hemodynamic
characteristics showed any signs of a failing heart (Table 1,
Figure 3). In addition, a reduced end-organ response to
autonomic nervous discharge does not seem likely to account for the
attenuated baroreflex sensitivity seen in this model of
atherosclerosis. As mentioned above, isolated
atherosclerotic vessels appear to be supersensitive to adrenergic
transmitters.6 7 8
In summary, this study provides data of Ang II effects on total
peripheral resistance in atherosclerotic animals. Ang II
increased total peripheral resistance by a greater degree
in rabbits fed cholesterol. Furthermore, baroreceptor
reflex sensitivity was markedly reduced. Thus, it is reasonable to
assume that the baroreflex blunted the vascular response to Ang II to a
lesser degree in atherosclerotic animals. In vivo, an attenuated
sensitivity of the baroreceptor reflex may, therefore, add to the
enhanced overall vascular responsiveness to Ang II associated with
atherosclerosis.
 |
Acknowledgments
|
|---|
The authors wish to thank Uta Stangenberg and Waltraud Piepke
for their technical assistance and Prof Dr Dietrich Kunze for
his
valuable help regarding the biochemical examinations.
Received June 2, 1999;
first decision June 28, 1999;
accepted September 29, 1999.
 |
References
|
|---|
-
Anitschkow N. Über die Veränderungen
der Kaninchenaorta bei experimenteller Cholesterinsteatose. Beitr
Pathol Anat. 1913;56:379404.
-
Song K, Shiota N, Takai S, Takashima H, Iwasaki H, Kim
S, Miyazaki M. Induction of angiotensin converting enzyme
and angiotensin II receptors in the atherosclerotic aorta
of high-cholesterol fed cynomolgus monkeys.
Atherosclerosis. 1998;138:171182.[Medline]
[Order article via Infotrieve]
-
Yang BC, Phillips MI, Mohuczy D, Meng H, Shen L, Mehta
P, Mehta JL. Increased angiotensin II type 1 receptor
expression in hypercholesterolemic
atherosclerosis in rabbits. Arterioscler Thromb
Vasc Biol. 1998;18:14331439.[Abstract/Free Full Text]
-
Wilson PW, Hoeg JM, DAgostino RB, Silbershatz H,
Belanger AM, Poehlmann H, OLeary D, Wolf PA. Cumulative effects of
high cholesterol levels, high blood pressure, and cigarette
smoking on carotid stenosis. N Engl J Med. 1997;337:516522.[Abstract/Free Full Text]
-
Nazzaro P, Manzari M, Merlo M, Triggiani R, Scarano A,
Ciancio L, Pirrelli A. Distinct and combined vascular effects of ACE
blockade and HMG-CoA reductase inhibition in hypertensive subjects.
Hypertension. 1999;33:719725.[Abstract/Free Full Text]
-
Rosendorff C, Hoffman JI, Verrier ED, Rouleau J,
Boerboom LE. Cholesterol potentiates the coronary
artery response to norepinephrine in anesthetized
and conscious dogs. Circ Res. 1981;48:320329.[Abstract/Free Full Text]
-
Heric E, Tackett RL. Altered vascular reactivity in
the rabbit during hypercholesterolemia.
Pharmacology. 1985;31:7281.[Medline]
[Order article via Infotrieve]
-
Tesfamariam B, Weisbrod RM, Cohen RA. Augmented
adrenergic contractions of carotid arteries from
cholesterol-fed rabbits due to endothelial
cell dysfunction. J Cardiovasc Pharmacol. 1989;13:820825.[Medline]
[Order article via Infotrieve]
-
Dam JP, Vleeming W, Riezebos J, Post MJ, Porsius AJ,
Wemer J. Effects of hypercholesterolemia on the
contractions to angiotensin II in the isolated aorta and
iliac artery of the rabbit: role of arachidonic acid
metabolites. J Cardiovasc Pharmacol. 1997;3:118123.
-
Carroll JF, Mizelle HL, Cockrell K, Reckelhoff JF,
Clower BR, Granger JP. Cholesterol feeding does not alter
renal hemodynamic response to acetylcholine and
angiotensin II in rabbits. Am J Physiol. 1997;272:R940R947.[Abstract/Free Full Text]
-
Hof RP, Hof A. Vasoconstrictor and vasodilator effects
in normal and atherosclerotic conscious rabbits. Br J
Pharmacol. 1988;95:10751080.[Medline]
[Order article via Infotrieve]
-
Stauss HM, Redlich T, Zhu YC, Adamiak D, Mott A, Kregel
KC, Unger T. Angiotensin-converting enzyme inhibition in
infarct-induced heart failure in rats: bradykinin versus
angiotensin II. J Cardiovasc Risk. 1994;1:255262.[Medline]
[Order article via Infotrieve]
-
Angell-James JE, Clarke JA, de Burgh Daly M, Taton A.
Carotid chemoreceptor function and structure in the atherosclerotic
rabbit: respiratory and cardiovascular responses to
hyperoxia, hypoxia and hypercapnia. Cardiovasc Res. 1989;23:541553.[Medline]
[Order article via Infotrieve]
-
Dickinson CJ, Yu R. The progressive pressor response to
angiotensin in the rabbit. J Physiol. 1967;190:9199.[Abstract/Free Full Text]
-
Zuckerman BD, Weisman HF, Yin FC. Arterial
hemodynamics in a rabbit model of
atherosclerosis. Am J Physiol. 1989;257:H891H897.[Abstract/Free Full Text]
-
Angell-James JE. Arterial baroreceptor
activity in rabbits with experimental atherosclerosis.
Circ Res. 1974;34:2739.[Abstract/Free Full Text]
-
Kamanna VS, Vora S, Roh D, Kirschenbaum MA. Comparative
studies on acid cholesterol esterase in renal blood vessels
and aorta of control and hypercholesterolemic rabbits.
Atherosclerosis. 1992;94:2733.[Medline]
[Order article via Infotrieve]
-
Morita H, Nishida Y, Motochigawa H, Watanabe Y, Hosomi
H. Depressed baroreflex control of renal nerve activity in conscious
WHHL rabbits. Cardiovasc Res. 1988;22:679685.[Medline]
[Order article via Infotrieve]
-
Vlachakis ND, Mendlowitz M, DGuia D, DGusman D.
Diminished baroreceptor sensitivity in elderly hypertensives: possible
role of atherosclerosis.
Atherosclerosis. 1976;24:243249.[Medline]
[Order article via Infotrieve]
-
Katsuda S, Hosomi H, Shiomi M, Watanabe Y. Impaired
baroreflex control of arterial pressure in WHHL rabbits.
J Vet Med Sci. 1992;54:983987.[Medline]
[Order article via Infotrieve]
-
Hosomi H, Katsuda S, Watanabe Y. Effect of
atherosclerosis on the responsiveness of the rapidly
acting arterial pressure control system in WHHL rabbits.
Cardiovasc Res. 1986;20:195200.[Medline]
[Order article via Infotrieve]
-
Li Z, Mao HZ, Abboud FM, Chapleau MW. Oxygen-derived
free radicals contribute to baroreceptor dysfunction in atherosclerotic
rabbits. Circ Res. 1996;79:802811.[Abstract/Free Full Text]
-
Mao HZ, Li Z, Chapleau MW. Platelet activation in
carotid sinuses triggers reflex sympathoinhibition and hypotension.
Hypertension. 1996;27(pt 2):584590.
-
Farrar DJ, Bond MG, Riley WA, Sawyer JK. Anatomic
correlates of aortic pulse wave velocity and carotid artery elasticity
during atherosclerosis progression and regression in
monkeys. Circulation. 1991;83:17541763.[Abstract/Free Full Text]
-
Chapleau MW, Cunningham JT, Sullivan MJ, Wachtel RE,
Abboud FM. Structural versus functional modulation of the
arterial baroreflex. Hypertension. 1995;26:341347.[Abstract/Free Full Text]
-
Willenbrock R, Stauss H, Scheuermann M, Osterziel KJ,
Unger T, Dietz R. Effect of chronic volume overload on baroreflex
control of heart rate and sympathetic nerve activity. Am J
Physiol. 1997;273(pt 2):H2580H2585.
-
Wang W, Chen JS, Zucker IH. Carotid sinus baroreceptor
reflex in dogs with experimental heart failure. Circ Res. 1991;68:12941301.[Abstract/Free Full Text]
This article has been cited by other articles:

|
 |

|
 |
 
H. M. Stauss and P. B. Persson
Role of Nitric Oxide in Buffering Short-Term Blood Pressure Fluctuations
Physiology,
October 1, 2000;
15(5):
229 - 233.
[Abstract]
[Full Text]
[PDF]
|
 |
|